iPSC-Derived Striatal Medium Spiny Neurons from Patients with Multiple System Atrophy Show Hypoexcitability and Elevated α-Synuclein Release

Cells. 2023 Jan 4;12(2):223. doi: 10.3390/cells12020223.

Abstract

Multiple system atrophy of the parkinsonian type (MSA-P) is a rare, fatal neurodegenerative disease with sporadic onset. It is still unknown if MSA-P is a primary oligodendropathy or caused by neuronal pathophysiology leading to severe, α-synuclein-associated neurodegeneration, mainly in the striatum. In this study, we generated and differentiated induced pluripotent stem cells (iPSCs) from patients with the clinical diagnosis of probable MSA-P (n = 3) and from three matched healthy controls into GABAergic striatal medium spiny neurons (MSNs). We found a significantly elevated release and neuronal distribution for α-synuclein, as well as hypoexcitability in the MSNs derived from the MSA-P patients compared to the healthy controls. These data suggest that the striatal hypoexcitable neurons of MSA-P patients contribute to a pathological α-synuclein burden which is likely to spread to neighboring cells and projection targets, facilitating disease progression.

Keywords: hypoexcitability; induced pluripotent stem cells (iPSCs); multiple system atrophy (MSA); striatal medium spiny neurons (MSNs); α-synuclein.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • GABAergic Neurons / pathology
  • Humans
  • Induced Pluripotent Stem Cells* / pathology
  • Medium Spiny Neurons
  • Multiple System Atrophy* / pathology
  • alpha-Synuclein

Substances

  • alpha-Synuclein

Grants and funding

This research was funded by the Deutsche Forschungsgemeinschaft (DFG) to G.H., grant number HO 2402/18-1 MSAomics. N.J.S. and F.W. were supported by Karlheinz-Hartmann-Stiftung (Hannover, Germany).